Charles River Laboratories International, Inc. (CRL)
NYSE ยท Healthcare ยท Medical - Diagnostics & Research
Market Cap$14.11B
SectorHealthcare
IndustryMedical - Diagnostics & Research
52-Week Low$145.47
52-Week High$303.31
CEOBirgit Girshick
IPO DateJun 23, 2000
Employees19,000
CountryUnited States
Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region.